Pharmac has included the weight-loss drug Wegovy in its future funding list, with eligibility based on BMI and comorbidities, amid concerns over cost and effectiveness.
Stacked weekly counts; colour by lean. “n/a” covers government and iwi-Māori sources where lean isn't applicable.
How this topic has been named, week by week. A new alias winning out is usually a framing shift.
How the news corpus has covered this same topic over the last 12 weeks. 3 articles from RNZ, Stuff, NZ Herald, ODT, 1News, Newsroom and The Spinoff. Click through to the press view for the full panel.
Up to 12 framings spread across orientations. Each framing is a short phrase the topic extractor generated to characterise the piece's stance — not a quote from the source. Click through to read the original.
equity-driven health intervention
Can Wegovy move the needle on NZ’s obesity crisis, or simply treat its symptoms?Spotted something wrong on this page? Report a correction.